ArticleEndocrine2017

Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study.

Claudia Pivonello et al.PubMed ↗Publisher ↗

No numbers read from the abstract.